SPONSOR
National Heart, Lung, and Blood Institute (NHLBI)
Total Trials
9
Recruiting
9
Phases
Phase 2, Phase 1, Phase 2, Phase 1
Conditions studied: Chronic Lymphocytic LeukemiaLymphangioleiomyomatosisCADCardiovascular DiseaseCoronary DiseaseSevere Aplastic Anemia (SAA)Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)Vascular And Immunologic DiseasesHealthy Volunteers
NCT03986034 Phase 2
Recruiting
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia
NCT01799538 Phase 1, Phase 2
Recruiting
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Lymphangioleiomyomatosis
NCT03331380
Recruiting
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
CAD
NCT04927429
Recruiting
Technical Development of Cardiovascular Magnetic Resonance Imaging
Cardiovascular Disease
NCT04216342 Phase 1
Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
Cardiovascular Disease
NCT01621594
Recruiting
Evaluating New Radiation Techniques for Cardiovascular Imaging
Coronary Disease
NCT03520647 Phase 2
Recruiting
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
Severe Aplastic Anemia (SAA)
NCT05403151
Recruiting
Controls and Healthy Vasculature Initiative
Vascular And Immunologic Diseases
NCT00081523
Recruiting
Natural History of Sickle Cell Disease
Pain Crisis